We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

57 hedge funds and large institutions have $1.23B invested in SpringWorks Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

81% more capital invested

Capital invested by funds: $681M → $1.23B (+$552M)

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

30% more funds holding

Funds holding: 44 → 57 (+13)

2.01% more ownership

Funds ownership: 72.34% → 74.35% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
57
Holders Change
+13
Holders Change %
+29.55%
% of All Funds
1.12%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
26
Increased
14
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.48M
3
BI
BVF Inc
California
+$5.5M
4
DCM
Driehaus Capital Management
Illinois
+$5.29M
5
State Street
State Street
Massachusetts
+$3.4M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$9.31M
2
Citadel Advisors
Citadel Advisors
Florida
-$9.2M
3
DM
Deerfield Management
New York
-$6.15M
4
LCM
Laurion Capital Management
New York
-$3.38M
5
SFM
Sphera Funds Management
Israel
-$2.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$5.07M +$3.08M +131,597 New
Carson Wealth (CWM LLC)
27
Carson Wealth (CWM LLC)
Nebraska
$4.45M – – –
OAM
28
Oxford Asset Management
United Kingdom
$3.99M -$1.52M -64,829 -38%
AA
29
ALPS Advisors
Colorado
$3.33M +$2.03M +86,603 New
Charles Schwab
30
Charles Schwab
California
$2.27M +$1.38M +58,931 New
N
31
Nuveen
North Carolina
$1.43M +$872K +37,240 New
AC
32
Athanor Capital
New York
$1.17M +$714K +30,512 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1M +$610K +26,081 New
Legal & General Group
34
Legal & General Group
United Kingdom
$954K +$577K +24,676 +12,654%
Prudential Financial
35
Prudential Financial
New Jersey
$703K +$427K +18,266 New
PPA
36
Parametric Portfolio Associates
Washington
$624K -$569K -24,311 -60%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$614K +$373K +15,947 New
Morgan Stanley
38
Morgan Stanley
New York
$595K +$212K +9,045 +141%
VEA
39
Virtus ETF Advisers
New York
$549K +$334K +14,253 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$363K +$221K +9,426 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$362K +$220K +9,400 New
SIM
42
Spark Investment Management
New York
$342K +$208K +8,900 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$319K +$194K +8,295 New
MIM
44
MetLife Investment Management
New Jersey
$315K +$192K +8,195 New
AIG
45
American International Group
New York
$252K +$153K +6,538 New
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$226K +$137K +5,860 New
Millennium Management
47
Millennium Management
New York
$220K -$9.31M -397,890 -99%
Deutsche Bank
48
Deutsche Bank
Germany
$147K +$89.8K +3,837 New
JP Morgan Chase
49
JP Morgan Chase
New York
$131K +$79.7K +3,404 New
SO
50
STRS Ohio
Ohio
$103K +$63.2K +2,700 New
1
2
3

SWTX Hedge Fund Activity: Q4 2019 in Review

57 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2019, worth a combined $1.23B — up 81% from $681M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new SWTX positions and 13 closed out — a net gain of 13 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $12.6M. The largest seller was Millennium Management, cutting an estimated $9.31M.

  • 57 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2019, up from 44 in Q3 2019.
  • Funds reported $1.23B of SpringWorks Therapeutics stock for Q4 2019, up 81% quarter-over-quarter.
  • 26 funds opened new SpringWorks Therapeutics positions in Q4 2019 and 13 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q4 2019 was BlackRock, an estimated $12.6M added.
  • The largest SpringWorks Therapeutics seller in Q4 2019 was Millennium Management, an estimated $9.31M sold.

Based on aggregated 13F filings for Q4 2019.